Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review

Area of Science:

• Gastroenterology
• Infectious Diseases
• Microbiology

Background:

• Clostridioides difficile infection (CDI) is a significant nosocomial infection, renamed from Clostridium difficile in 2016.
• CDI is prevalent in cirrhosis patients and adversely impacts prognosis.
• Understanding CDI in cirrhosis is crucial for clinical practice.

Purpose of the Study:

• To review the clinical implications of CDI in cirrhosis.
• To summarize current knowledge on risk factors, treatment, and prevention.

Main Methods:

• Literature review of studies on CDI in cirrhotic patients.
• Analysis of risk factors, treatment efficacy, and prevention strategies.

Main Results:

• CDI prevalence in cirrhosis is increasing, but mortality is decreasing.
• Risk factors include antibiotic use, cirrhosis severity, comorbidities, and demographics.
• Rifaximin and lactulose may reduce CDI risk; fecal microbiota transplantation shows safety and efficacy for recurrent CDI.

Conclusions:

• CDI management in cirrhosis requires tailored approaches.
• Further prospective studies are needed to validate treatment efficacy.
• Prevention relies on strict hygiene and environmental cleaning, not widespread screening.